MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Abbott advises against mini-tender offer

Abbott advises against mini-tender offer

By

Abbott LogoAbbott (NYSE: ABT) appears to be part of the trend of large companies advising their shareholders to avoid unsolicited mini-tender offers.

The Abbott Park, Illinois–based maker of diagnostics, medical devices, nutritionals and branded generic medicines posted a news release today in which it advised shareholders to ignore an unsolicited mini-tender offer from TRC Capital Investment Corp. (TRC).

Mini-tender offers seek to buy less than 5% of a company’s shares from investors, enabling the offerer to avoid making the type of disclosures that the U.S. Securities and Exchange Commission requires of larger offerers. The SEC has cautioned investors to carefully scrutinize mini-tender offers to ensure they aren’t being caught off-guard on the price.

The TRC offer, scheduled to expire shortly after midnight on May 17, would purchase up to 1 million Abbott shares, representing 0.06% of the company’s outstanding shares, according to Abbott.

Said Abbott: “TRC’s offer price of $112.38 per share in cash is approximately 4.5% lower than the $117.69 closing price of Abbott common shares on April 14, 2022, the last closing price prior to commencement of the offer.

“Abbott does not recommend or endorse TRC’s unsolicited below-market mini-tender offer and recommends that shareholders not tender their shares because the offer is at a price significantly below the current market price of Abbott common shares.”

ABT shares were down more than 1%, at $118.06 apiece, in morning trading today. MassDevice’s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was down 1.6%.

 

In case you missed it

RSS From Medical Design & Outsourcing

  • FDA may order Philips to resolve respiratory devices recall
    The FDA has proposed an order requiring Philips (NYSE:PHG) to submit a plan for its recalled respiratory devices. FDA’s proposal regards the June 2021 recall of millions of certain Philips ventilators, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) machines due to potential health risks caused by polyester-based polyurethane (PE-PUR) sound abatement foam breaking… […]
  • DeviceTalks Boston hosting MedTech Innovator mid-stage pitch competitions on May 10-11
    Twenty-five mid-stage medical device startups will pitch their exciting medtech stories at DeviceTalks Boston on May 10-11 at the Boston Convention & Exhibition Center as part of the MedTech Innovator Mid-Stage Companies Pitch Event.  The pitch event is thanks to a new partnership between DeviceTalks, organizer of a portfolio of events and podcasts serving the… […]
  • Titan Medical inks a $2.6M purchase order from Medtronic
    Robotic-assisted surgery company Titan Medical (Nasdaq: TMDI; TSX: TMD) is deepening its relationship with Medtronic (NYSE:MDT), securing a $2.6 million purchase order from the medtech giant. The purchase order news comes more than three months after Titan Medical completed a development and licensing agreement with Medtronic that brought in a net $8.3 million, helping the… […]
  • MDMA elects Outset CEO Leslie Trigg as chair
    The Medical Device Manufacturers Association (MDMA) has elected Outset Medical Chair and CEO Leslie Trigg as chair of the trade group’s board of directors. MDMA announced the leadership change today, following the Washington, D.C.–based industry association’s annual meeting last week. “Medical technology innovators are at the forefront of improving patient outcomes and reducing the cost… […]
  • FDA warns of risk from Medtronic silicone-based EMG endotracheal tubes
    The FDA is evaluating the risk of Medtronic (NYSE:MDT) silicone-based electromyogram (EMG) endotracheal tubes following reports of deaths and serious adverse events. The FDA issued the warning last week in a letter to healthcare providers concerning the Medtronic NIM Standard Reinforced EMG Endotracheal Tubes and Medtronic NIM Contact Reinforced EMG Endotracheal Tubes. They are the only… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • Cordis high resolution electronic proportional pressure controls
    Precise, linear pressure control within a closed-loop system with ultra-high resolution and repeatability The Clippard Cordis is a revolutionary microcontroller primed for escape velocity from a proportional control market that has grown stagnant. Built with the highest quality Clippard proportional valves at its heart, the Cordis is designed to outperform the competition in every way. With… […]
  • Proven Humidity Control for Medical Device Development
    When a new development cycle begins for a device meant to monitor a patient’s respiratory condition, manufacturers should consider the challenges their design will face with humidity. Humidity is a catalyst for disruption, as it increases the risk of costly device damage and affects analysis of patients’ respiratory state. Too much moisture in the device… […]
  • Johnson & Johnson shareholders approve racial justice audit proposal
    Johnson & Johnson (NYSE: JNJ) investors voted in support of a proposal for a third-party racial justice audit at the annual shareholder meeting. It was the only shareholder proposal to pass at yesterday’s annual meeting, where investors also considered proposals to discontinue global sales of baby powder containing talc, to study the public health costs… […]
  • Medtronic investigates HVAD pump welds after patient deaths
    Medtronic (NYSE:MDT) is investigating a new problem with its HeartWare Ventricular Assist Device (HVAD) nearly one year after halting sales and new device implantations. Fridley, Minnesota–based Medtronic said it received three complaints of suspected pump thrombosis in patients. Two of the patients died after their heart pumps were exchanged. Medtronic found a malfunction when inspecting the… […]
  • Integer misses on Q1, adjusts full-year outlook
    Integer Holdings (NYSE:ITGR) posted first-quarter results today that fell short of the consensus forecast on Wall Street and adjusted its outlook for the rest of the year to include its recent acquisition of Aran Biomedical. The Plano, Texas–based medical device contract manufacturing giant reported profits of $11 million, or $0.34 per diluted share, on sales of… […]